FibroBiologics Quote - FBLG

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

2.35

Bid

2.30

Ask

2.37

Volume

1,621

2.32 Day's Range 2.35

1.0779 52 Week Range 55.00

Market Cap

81.449M

Previous Close

2.36

Open

2.35

Last Trade

2.335

Last Trade Time

08:30:04

Financial Volume

US$ 3,809

VWAP

2.35

Average Volume (3m)

157,029

Shares Outstanding

34,659,125

Dividend Yield

PE Ratio

-4.29

Earnings Per Share (EPS)

-0.55

Revenue

Net Profit

-19.06M

FibroBiologics, Inc. operates as a clinical-stage cell therapy company that focuses on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs. The company develops CybroCell for degenerative disc disease; CYMS101 to... FibroBiologics, Inc. operates as a clinical-stage cell therapy company that focuses on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs. The company develops CybroCell for degenerative disc disease; CYMS101 to treat multiple sclerosis; and CYWC628 for treating wound healing. Its early-stage research programs include CYTER915 which is designed to regenerate or reinvigorate production of the thymus and/or spleen; and TCB190 for the treatment of cancers. The company was incorporated in 2021 and is based in Houston, Texas. FibroBiologics, Inc. operates as a subsidiary of Spinalcyte Llc. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.fibrobiologics.com

Headquarters

Wilmington, Delaware, USA

Founded

FibroBiologics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker FBLG. The last closing price for FibroBiologics was US$2.36. Over the last year, FibroBiologics shares have traded in a share price range of US$ 1.0779 to US$ 55.00.

FibroBiologics currently has 34,659,125 shares outstanding. The market capitalization of FibroBiologics is US$81.80 million. FibroBiologics has a price to earnings ratio (PE ratio) of -4.29.

Form S-1 - General form for registration of securities under the Securities Act of 1933

Form 8-K - Current report

FibroBiologics Announces $25 Million Financing

HOUSTON, Dec. 23, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics”), a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on the...

Form 8-K - Current report

FibroBiologics Files Patent Application for a Cell-based Therapeutic for the Treatment Of Splenomegaly

HOUSTON, Nov. 19, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) , a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on the development of...

FibroBiologics Files Patent Application Covering Reduction of Blood Clots Associated with Instant Blood-Mediated Inflammatory Reaction (IBMIR) in Cell-Based Therapeutics

HOUSTON, Nov. 14, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on the...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.01	-0.423728813559	2.36	2.51	2.02	146986	2.25632147	CS
4	-0.35	-12.962962963	2.7	2.79	1.93	124125	2.30058839	CS
12	-0.51	-17.8321678322	2.86	3.89	1.93	157029	2.78635938	CS
26	-2.49	-51.4462809917	4.84	5.62	1.0779	294970	3.09438085	CS
52	-27.65	-92.1666666667	30	55	1.0779	240512	5.05939085	CS
156	-27.65	-92.1666666667	30	55	1.0779	240512	5.05939085	CS
260	-27.65	-92.1666666667	30	55	1.0779	240512	5.05939085	CS

FBLG - Frequently Asked Questions (FAQ)

What is the current FibroBiologics share price?

The current share price of FibroBiologics is US$ 2.35

How many FibroBiologics shares are in issue?

FibroBiologics has 34,659,125 shares in issue

What is the market cap of FibroBiologics?

The market capitalisation of FibroBiologics is USD 81.8M

What is the 1 year trading range for FibroBiologics share price?

FibroBiologics has traded in the range of US$ 1.0779 to US$ 55.00 during the past year

What is the PE ratio of FibroBiologics?

The price to earnings ratio of FibroBiologics is -4.29

What is the reporting currency for FibroBiologics?

FibroBiologics reports financial results in USD

What is the latest annual profit for FibroBiologics?

The latest annual profit of FibroBiologics is USD -19.06M

What is the registered address of FibroBiologics?

The registered address for FibroBiologics is CORPORATION TRUST CENTER, 1209 ORANGE ST, NEW CASTLE, WILMINGTON, DELAWARE, 19801

What is the FibroBiologics website address?

The website address for FibroBiologics is www.fibrobiologics.com

Which industry sector does FibroBiologics operate in?

FibroBiologics operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
AALAmerican Airlines Group Inc	US$ 17.34 (0.00%)	276.91k
AAGRAfrican Agriculture Holdings Inc	US$ 0.1326 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	US$ 69.73 (0.00%)	0
AADIAadi Bioscience Inc	US$ 3.21 (0.00%)	4.84k
AACGATA Creativity Global	US$ 0.762551 (0.00%)	0
AALAmerican Airlines Group Inc	US$ 17.34 (0.00%)	282.45k
AAGRAfrican Agriculture Holdings Inc	US$ 0.1326 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	US$ 69.73 (0.00%)	0
AADIAadi Bioscience Inc	US$ 3.21 (0.00%)	4.84k
AACGATA Creativity Global	US$ 0.762551 (0.00%)	0
NXUNXU Inc	US$ 0.2434 (0.00%)	125.6M
WATTEnergous Corporation	US$ 0.4112 (0.00%)	65.68M
VINCVincerx Inc	US$ 0.194 (0.00%)	28.14M
INTZIntrusion Inc	US$ 2.16 (0.00%)	27.09M
HOLOMicroCloud Hologram Inc	US$ 2.40 (0.00%)	26.76M